These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12534393)

  • 21. Telomeres and telomerase. A survey about methods and recent advances in cancer diagnostic and therapy.
    Weise JM; Günes C
    Histol Histopathol; 2006 Nov; 21(11):1249-61. PubMed ID: 16874667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessing responses to cancer therapy using molecular imaging.
    Neves AA; Brindle KM
    Biochim Biophys Acta; 2006 Dec; 1766(2):242-61. PubMed ID: 17140737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptionally targeted gene therapy to detect and treat cancer.
    Wu L; Johnson M; Sato M
    Trends Mol Med; 2003 Oct; 9(10):421-9. PubMed ID: 14557054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic Immunotherapy for Treatment of Cancer.
    Tsun A; Miao XN; Wang CM; Yu DC
    Adv Exp Med Biol; 2016; 909():241-83. PubMed ID: 27240460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personalised medicine for cancer: from drug development into clinical practice.
    Jain KK
    Expert Opin Pharmacother; 2005 Aug; 6(9):1463-76. PubMed ID: 16086635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the human genome in cancer with genomic approaches.
    Scheel JR; Kuo MD
    J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971
    [No Abstract]   [Full Text] [Related]  

  • 29. Revealing targeted therapy for human cancer by gene module maps.
    Wong DJ; Nuyten DS; Regev A; Lin M; Adler AS; Segal E; van de Vijver MJ; Chang HY
    Cancer Res; 2008 Jan; 68(2):369-78. PubMed ID: 18199530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel strategies for therapeutic design in molecular oncology using gene expression profiles.
    Ricci MS; el-Deiry WS
    Curr Opin Mol Ther; 2000 Dec; 2(6):682-90. PubMed ID: 11249746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Better blocker: RNA interference dazzles research community.
    Garber K
    J Natl Cancer Inst; 2003 Apr; 95(7):500-2. PubMed ID: 12671010
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF; Burns J; Ditzel HJ
    Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNAs as pharmacological targets in cancer.
    Soriano A; Jubierre L; Almazán-Moga A; Molist C; Roma J; de Toledo JS; Gallego S; Segura MF
    Pharmacol Res; 2013 Sep; 75():3-14. PubMed ID: 23537752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
    Bristow RG; Alexander B; Baumann M; Bratman SV; Brown JM; Camphausen K; Choyke P; Citrin D; Contessa JN; Dicker A; Kirsch DG; Krause M; Le QT; Milosevic M; Morris ZS; Sarkaria JN; Sondel PM; Tran PT; Wilson GD; Willers H; Wong RKS; Harari PM
    Lancet Oncol; 2018 May; 19(5):e240-e251. PubMed ID: 29726389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs in the Diagnosis and Treatment of Cancer.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Immunol Invest; 2017 Nov; 46(8):880-897. PubMed ID: 29058545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics for cancer management in the post-genome era.
    Katoh M; Katoh M
    Technol Cancer Res Treat; 2006 Apr; 5(2):169-75. PubMed ID: 16551136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Cancer Vaccines.
    Ye Z; Li Z; Jin H; Qian Q
    Adv Exp Med Biol; 2016; 909():139-67. PubMed ID: 27240458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Array-based pharmacogenomics of molecular-targeted therapies in oncology.
    Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D
    Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atelocollagen-mediated siRNA delivery: future promise for therapeutic application.
    Fujimoto I; Takei Y
    Ther Deliv; 2014 Apr; 5(4):369-71. PubMed ID: 24856162
    [No Abstract]   [Full Text] [Related]  

  • 40. Epigenetics and cancer.
    Kanwal R; Gupta S
    J Appl Physiol (1985); 2010 Aug; 109(2):598-605. PubMed ID: 20203073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.